Amylyx Pharmaceuticals, Inc. AMLX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s change in lease liabilities?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported change in lease liabilities of -$327K in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s change in lease liabilities changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s change in lease liabilities increased by 45.4% year-over-year, from -$599K to -$327K.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s change in lease liabilities?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s change in lease liabilities has grown at a 8.9% compound annual growth rate (CAGR), from -$917K to -$1.19M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.